Science that

REVOLUTIONIZES

Using key discoveries in the field of liver health, we’re innovating treatment for progressive non-viral liver diseases, solving some of today’s toughest medical challenges and building healthier tomorrows.

FARNESOID X RECEPTOR

Research is shedding light on the complex and powerful connection between bile acid and the farnesoid X receptor (FXR). Understand the metabolic effects of FXR.

Clinical
Trials

We are conducting and currently recruiting for several clinical trials.

OUR PIPELINE

Intercept is expanding its pipeline to feature new indications for liver diseases with limited therapeutic options. Take a look at the direction we are going.

Learn more

DISCOVERY COMPOUNDS

Intercept is focused on developing our lead compound, obeticholic acid, but we are also looking into the future with 2 novel compounds.

Learn more

MEDICAL INFORMATION

If you are a healthcare professional and have a medical inquiry, visit our Medical Information website.

LEARN MORE